Skip to main content
. 2018 Feb 12;15(4):5879–5886. doi: 10.3892/ol.2018.8030

Figure 3.

Figure 3.

Survival curves of patients with CRC and different expression levels of GRK6 as assessed by Kaplan-Meier method and the log-rank test. (A) The overall survival rate in patients with high expression levels of GRK6 was significantly lower compared with patients with low expression levels of GRK6. (B) The overall survival rate in patients with stage I–II CRC with high GRK6 expression was significantly lower compared with corresponding patients with low expression levels of GRK6 (P=0.029). (C) The overall survival rate in patients with stage III–IV CRC with high expression levels of GRK6 was significantly lower compared with corresponding patients with low expression levels of GRK6 (P<0.0001). CRC, colorectal carcinoma; GRK6, G protein-coupled receptor kinase 6; TNM, tumor-node-metastasis.